MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer

Ofra Novoplansky, Matthew Fury, Manu Prasad, Ksenia Yegodayev, Jonathan Zorea, Limor Cohen, Raphael Pelossof, Liz Cohen, Nora Katabi, Fabiola Cecchi, Ben Zion Joshua, Aron Popovtzer, Jose Baselga, Maurizio Scaltriti, Moshe Elkabets

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science